Details for Patent: 7,160,559

✉ Email this page to a colleague

Summary for Patent: 7,160,559

Patent landscape, scope, and claims:

Title:	Controlled release galantamine composition
Abstract:	The present invention is concerned with controlled release compositions for oral administration comprising galantamine; and with processes of preparing such controlled release compositions.
Inventor(s):	McGee; John Paul (Antwerp, BE), Gilis; Paul Marie Victor (Beerse, BE), De Weer; Marc Maurice Germain (Vosselaar, BE), de Conde; Valentin Florent Victor (Lommel, BE), de Bruijn; Herman Johannes Catherina (Meer, BE), Van Dycke; Frederic Anne Rodolf (Antwerp, BE)
Assignee:	Janssen Pharmaceutica N.V. (Beerse, BE)
Application Number:	09/868,991
Patent Claim Types: see list of patent claims	Formulation; Compound; Device; Process; Use; Dosage form;
More… ↓ ⤷ Subscribe

Drugs Protected by US Patent 7,160,559

Glossary

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 7,160,559

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
	98204447	Dec 24, 1998

PCT Information
PCT Filed	December 20, 1999	PCT Application Number:	PCT/EP99/10257
PCT Publication Date:	July 06, 2000	PCT Publication Number:	WO00/38686

International Family Members for US Patent 7,160,559

Subscribe to access the full database, or Subscribe
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
African Regional IP Organization (ARIPO)	1414	⤷ Subscribe
Argentina	022008	⤷ Subscribe
Argentina	066313	⤷ Subscribe
Austria	252386	⤷ Subscribe
Australia	2100600	⤷ Subscribe
Australia	775914	⤷ Subscribe
Bulgaria	105564	⤷ Subscribe
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.